No Compelling Evidence to Use Warfarin or Aspirin in HF Patients

Summary

The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial [WARCEF; NCT00041938] found no compelling evidence to use warfarin for all patients according to outcomes from the study.

  • Cerebrovascular Disease
  • Heart Failure Clinical Trials
  • Cerebrovascular Disease
  • Ischemia
View Full Text